Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.
Lortholary O, Chandesris MO, Bulai Livideanu C, Paul C, Guillet G, Jassem E, Niedoszytko M, Barete S, Verstovsek S, Grattan C, Damaj G, Canioni D, Fraitag S, Lhermitte L, Georgin Lavialle S, Frenzel L, Afrin LB, Hanssens K, Agopian J, Gaillard R, Kinet JP, Auclair C, Mansfield C, Moussy A, Dubreuil P, Hermine O. Lortholary O, et al. Among authors: barete s. Lancet. 2017 Feb 11;389(10069):612-620. doi: 10.1016/S0140-6736(16)31403-9. Epub 2017 Jan 7. Lancet. 2017. PMID: 28069279 Free PMC article. Clinical Trial.
[Treatment of systemic mastocytosis].
Marrache F, Mémain N, Bonté I, Barete S, Casassus P, de Gennes C, Fain O, Hermine O, Lortholary O. Marrache F, et al. Among authors: barete s. Rev Med Interne. 2003 Sep;24(9):594-601. doi: 10.1016/s0248-8663(03)00141-3. Rev Med Interne. 2003. PMID: 12951180 Review. French.
Interest of interferon alpha in systemic mastocytosis. The French experience and review of the literature.
Simon J, Lortholary O, Caillat-Vigneron N, Raphaël M, Martin A, Brière J, Barète S, Hermine O, Casassus P; Group AFIRMM (Association française pour les initiatives de recherche sur le mastocyte et les mastocytoses). Simon J, et al. Among authors: barete s. Pathol Biol (Paris). 2004 Jun;52(5):294-9. doi: 10.1016/j.patbio.2004.04.012. Pathol Biol (Paris). 2004. PMID: 15217717 Review.
[Systemic mastocytosis].
Fain O, Stirnemann J, Eclache V, Barete S, Casassus P, Hermine O, Lorholary O. Fain O, et al. Among authors: barete s. Presse Med. 2005 May 14;34(9):681-7. doi: 10.1016/s0755-4982(05)84013-8. Presse Med. 2005. PMID: 15988348 Review. French.
Phenotypic and genotypic characteristics of mastocytosis according to the age of onset.
Lanternier F, Cohen-Akenine A, Palmerini F, Feger F, Yang Y, Zermati Y, Barète S, Sans B, Baude C, Ghez D, Suarez F, Delarue R, Casassus P, Bodemer C, Catteau A, Soppelsa F, Hanssens K, Arock M, Sobol H, Fraitag S, Canioni D, Moussy A, Launay JM, Dubreuil P, Hermine O, Lortholary O; AFIRMM network. Lanternier F, et al. Among authors: barete s. PLoS One. 2008 Apr 9;3(4):e1906. doi: 10.1371/journal.pone.0001906. PLoS One. 2008. PMID: 18404201 Free PMC article.
[Current concepts and treatment advances in systemic mastocytosis].
Georgin-Lavialle S, Barete S, Suarez F, Lepelletier Y, Bodemer C, Dubreuil P, Lortholary O, Hermine O. Georgin-Lavialle S, et al. Among authors: barete s. Rev Med Interne. 2009 Jan;30(1):25-34. doi: 10.1016/j.revmed.2008.01.025. Epub 2008 Apr 10. Rev Med Interne. 2009. PMID: 18406017 Review. French.
Case-control cohort study of patients' perceptions of disability in mastocytosis.
Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C, Cohen-Akenine A, Palmérini F, Hanssens K, Yang Y, Sobol H, Fraytag S, Ghez D, Suarez F, Barete S, Casassus P, Sans B, Arock M, Kinet JP, Dubreuil P, Moussy A. Hermine O, et al. Among authors: barete s. PLoS One. 2008 May 28;3(5):e2266. doi: 10.1371/journal.pone.0002266. PLoS One. 2008. PMID: 18509466 Free PMC article.
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.
Bodemer C, Hermine O, Palmérini F, Yang Y, Grandpeix-Guyodo C, Leventhal PS, Hadj-Rabia S, Nasca L, Georgin-Lavialle S, Cohen-Akenine A, Launay JM, Barete S, Feger F, Arock M, Catteau B, Sans B, Stalder JF, Skowron F, Thomas L, Lorette G, Plantin P, Bordigoni P, Lortholary O, de Prost Y, Moussy A, Sobol H, Dubreuil P. Bodemer C, et al. Among authors: barete s. J Invest Dermatol. 2010 Mar;130(3):804-15. doi: 10.1038/jid.2009.281. Epub 2009 Oct 29. J Invest Dermatol. 2010. PMID: 19865100 Free article.
Gastrointestinal involvement and manifestations in systemic mastocytosis.
Sokol H, Georgin-Lavialle S, Grandpeix-Guyodo C, Canioni D, Barete S, Dubreuil P, Lortholary O, Beaugerie L, Hermine O. Sokol H, et al. Among authors: barete s. Inflamm Bowel Dis. 2010 Jul;16(7):1247-53. doi: 10.1002/ibd.21218. Inflamm Bowel Dis. 2010. PMID: 20162539 Review.
Systemic mastocytosis and bone involvement in a cohort of 75 patients.
Barete S, Assous N, de Gennes C, Grandpeix C, Feger F, Palmerini F, Dubreuil P, Arock M, Roux C, Launay JM, Fraitag S, Canioni D, Billemont B, Suarez F, Lanternier F, Lortholary O, Hermine O, Francès C. Barete S, et al. Ann Rheum Dis. 2010 Oct;69(10):1838-41. doi: 10.1136/ard.2009.124511. Epub 2010 Jun 22. Ann Rheum Dis. 2010. PMID: 20570833
160 results